Medpace Voice

Clinical and Regulatory Considerations for Advancing Urinary Tract Infection (UTI) Drug Development in Women

Explore insights from Medpace medical and operational experts as they identify key themes from ESCMID Global 2025.

In this webinar, experts will provide a comprehensive overview of the current state of the clinical development landscape for rheumatology, along with strategies to drive…

As biopharmaceutical companies seek to optimize clinical trial design, accelerate regulatory approvals, and improve patient outcomes, insights from JSMO 2025 provide a critical foundation for…

In January 2025, the FDA released updated guidance titled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.” The FDA...

Every cancer journey is unique—shaped by the individual, the disease, and the evolving landscape of treatment.

Medpace medical, regulatory, and biostatistics experts identify key differences between the FDA’s 2007 and 2025 guidance documents on developing products...

Watch the on-demand Rare Disease Day webinar to explore strategies for cross-border patient enrollment and retention.

In the following video series, Medpace experts across North America, Europe, Latin America, and Asia Pacific will explore how our ID&V team enhances the success…

ASH 2024 Highlights:
Advancing Therapeutic Scalability, Precision Medicine, and Next-Gen Trial Designs